Tags

Type your tag names separated by a space and hit enter

MS-based methods for biomarkers of Parkinson's disease: what is the future?
Bioanalysis. 2015; 7(2):149-51.B

Authors+Show Affiliations

Medical Proteom-Center, Faculty of Medicine, Ruhr-Universität Bochum, Universitätsstr. 150, 44801 Bochum, Germany.No affiliation info availableNo affiliation info available

Pub Type(s)

Editorial
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

25587831

Citation

Barkovits, Katalin, et al. "MS-based Methods for Biomarkers of Parkinson's Disease: what Is the Future?" Bioanalysis, vol. 7, no. 2, 2015, pp. 149-51.
Barkovits K, Helling S, Marcus K. MS-based methods for biomarkers of Parkinson's disease: what is the future? Bioanalysis. 2015;7(2):149-51.
Barkovits, K., Helling, S., & Marcus, K. (2015). MS-based methods for biomarkers of Parkinson's disease: what is the future? Bioanalysis, 7(2), 149-51. https://doi.org/10.4155/bio.14.273
Barkovits K, Helling S, Marcus K. MS-based Methods for Biomarkers of Parkinson's Disease: what Is the Future. Bioanalysis. 2015;7(2):149-51. PubMed PMID: 25587831.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - MS-based methods for biomarkers of Parkinson's disease: what is the future? AU - Barkovits,Katalin, AU - Helling,Stefan, AU - Marcus,Katrin, PY - 2015/1/15/entrez PY - 2015/1/15/pubmed PY - 2015/9/12/medline KW - ELISA KW - quantitative mass spectrometry KW - synucleopathies SP - 149 EP - 51 JF - Bioanalysis JO - Bioanalysis VL - 7 IS - 2 SN - 1757-6199 UR - https://www.unboundmedicine.com/medline/citation/25587831/MS_based_methods_for_biomarkers_of_Parkinson's_disease:_what_is_the_future L2 - https://www.future-science.com/doi/abs/10.4155/bio.14.273?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub=pubmed DB - PRIME DP - Unbound Medicine ER -